Summary

The global Healthcare analytics market is projected to reach 133.19 billion by 2029 from 44.83 billion in 2024, at a CAGR of 24.3 % from 2024 to 2029. The widespread adoption of Electronic Health Records (EHR) is accelerating the growth of the healthcare analytics market. In North America, approximately 78% of office-based physicians and 96% of non-federal acute care hospitals use EHR systems, which are supported by regulatory incentives such as the HITECH Act. Europe has varying adoption rates, with the Netherlands at 97% and an average of 81% across the continent, indicating a high potential for analytics integration. Increased adoption of EHRs improves data accessibility and drives the demand for advanced analytics solutions.
“Healthcare analytics , clinical analytics segment to witness the highest growth during the forecast period.”
Based on application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operations & administrative analytics and population health analytics. The clinical analytics segment held the largest market share in 2023. Value-Based Care, technological advancements, and improved patient outcomes drive clinical analytics growth by focusing on outcome-based performance, optimizing costs, and enabling personalized, data-driven care through AI and EHR systems. This enhances care quality and efficiency, boosting the healthcare analytics market.
“APAC is estimated to register the highest CAGR during the forecast period.”
In this report, the healthcare analytics market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare analytics market in APAC is projected to register the highest CAGR rate during the forecast period. The APAC healthcare analytics market is groqing due to affordable medical treatments, such as average cost of bypass surgery in APAC region is approximately USD 4000, compared to USD 30,000 to USD 200,000 in the US. Moreover, government support for medical tourism, healthcare infrastructure investment, IT expansion, and a growing aging population with chronic diseases collectively strengthen the region's position in global healthcare.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.
• By Company Type: Tier 1 – 45%, Tier 2 – 35%, and Tier 20%
• By Designation: C-level Executives – 50%, Directors – 30%, and Others – 20%
• By Region: North America– 40%, Europe – 35%, Asia Pacific– 20% and RoW- 5%
Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US) are some of the key players in the healthcare analytics market.
The study includes an in-depth competitive analysis of these key players in the healthcare analytics market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the healthcare analytics market by component (Services, Software), by type (Descriptive analytics, Predictive analytics, Prescriptive analytics, Diagnostic analytics), by application (Financial analytics, Clinical analytics, Operations & Administration analytics, Population Health analytics), by end-user (Payers, Providers, Pharmaceutical & Medical device supply chain) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the healthcare analytics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the healthcare analytics market. Competitive analysis of upcoming startups in the healthcare analytics market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare analytics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (Government initiatives to increase EHR adoption, Growing venture capital investments in healthcare analytics start-ups, Growing pressure to curb healthcare spending and improve patient outcomes, Heterogeneity and complexity of big data in healthcare, Growing focus on real-world evidence, Cost Management and Operational Efficiency, Rise of Telemedicine and Remote Monitoring, Regulatory Compliance and Quality Improvement, Increasing demand for data-driven decision-making), restraints (High cost of analytics solutions in healthcare organizations, Rising data breach concerns), opportunities (Increasing focus on value-based medicines, Use of analytics in precision and personalized medicines, Cloud-based analytics, Increasing number of patient registries, Emergence of social media and its impact on healthcare industry, Augmented analytics to supplement human intelligence, Analytics of healthcare things), and challenges (Concerns regarding inaccurate and inconsistent data, Reluctance to adopt healthcare analytics solutions in emerging countries, Data integration for coordinated care, Operational gaps between payers and providers, Dearth of skilled personnel) influencing the growth of the healthcare analytics market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare analytics market
• Market Development: Comprehensive information about lucrative markets – the report analyses the healthcare analytics market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare analytics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US), Inovalon (US), Mckesson Corporation (US), MedeAnalytics, Inc.(US), Cotiviti, Inc. (US), Exlservice Holdings, Inc. (US), Wipro (India), Apixio. (US); among others in healthcare analytics market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
1.3 STUDY SCOPE 39
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 39
1.3.2 INCLUSIONS AND EXCLUSIONS 40
1.3.3 YEARS CONSIDERED 40
1.4 CURRENCY CONSIDERED 40
1.5 STAKEHOLDERS 41
1.6 SUMMARY OF CHANGES 41
1.7 IMPACT OF AI/GEN AI 41
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH APPROACH 42
2.1.1 SECONDARY DATA 43
2.1.1.1 Key data from secondary sources 44
2.1.2 PRIMARY DATA 44
2.1.2.1 Key data from primary sources 45
2.1.2.2 Insights from primary experts 46
2.2 RESEARCH METHODOLOGY DESIGN 47
2.3 MARKET SIZE ESTIMATION METHODOLOGY 48
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 54
2.5 RESEARCH ASSUMPTIONS 55
2.6 RESEARCH LIMITATIONS 55
2.6.1 METHODOLOGY-RELATED LIMITATIONS 55
2.6.2 SCOPE-RELATED LIMITATIONS 56
2.7 RISK ASSESSMENT 56
3 EXECUTIVE SUMMARY 57
4 PREMIUM INSIGHTS 61
4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW 61
4.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SHARE, BY END USER AND COUNTRY (2023) 62
4.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY 63
4.4 HEALTHCARE ANALYTICS MARKET: REGIONAL MIX 63
4.5 HEALTHCARE ANALYTICS MARKET: EMERGING ECONOMIES VS. DEVELOPED COUNTRIES 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
5.2.1 DRIVERS 66
5.2.1.1 Favorable government initiatives for electronic health record adoption 66
5.2.1.2 Growing venture capital investments in startups 67
5.2.1.3 Need to reduce healthcare costs 67
5.2.1.4 Increasing focus on real-world evidence 68
5.2.1.5 Rise of telemedicine and remote patient monitoring 69
5.2.1.6 Growing focus on regulatory compliance 69
5.2.2 RESTRAINTS 70
5.2.2.1 High cost of analytics solutions 70
5.2.2.2 Growing concerns about data breach 70
5.2.3 OPPORTUNITIES 73
5.2.3.1 Increasing focus on value-based medicines 73
5.2.3.2 Growing use of analytics in healthcare 74
5.2.3.3 Rising number of patient registries 75
5.2.3.4 Emergence of social media and digital health technologies 75
5.2.4 CHALLENGES 75
5.2.4.1 Concerns regarding inaccurate and inconsistent data 75
5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries 76
5.2.4.3 Lack of maintenance of medical records 76
5.2.4.4 Shortage of skilled personnel 76
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 77
5.4 INDUSTRY TRENDS 78
5.4.1 INCREASING PARTNERSHIPS AND COLLABORATIONS AMONG MARKET PLAYERS 78
5.4.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS 78
5.4.3 GROWING ADOPTION OF CLOUD-BASED IT SOLUTIONS 79
5.5 ECOSYSTEM ANALYSIS 80
5.6 VALUE CHAIN ANALYSIS 82
5.7 TECHNOLOGY ANALYSIS 83
5.7.1 KEY TECHNOLOGIES 83
5.7.1.1 Big data analytics 83
5.7.1.2 Artificial intelligence and machine learning 84
5.7.1.3 Business intelligence tools 84
5.7.2 ADJACENT TECHNOLOGIES 85
5.7.2.1 Cloud computing 85
5.7.2.2 Internet of things 85
 
5.8 REGULATORY LANDSCAPE 86
5.8.1 REGULATORY ANALYSIS 86
5.8.2 GOVERNMENT REGULATIONS 89
5.8.2.1 US 89
5.8.2.2 Europe 89
5.8.2.3 China 89
5.8.2.4 Japan 89
5.8.2.5 India 90
5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
5.9 PRICING ANALYSIS 92
5.9.1 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT 93
5.9.2 AVERAGE SELLING PRICE, BY REGION 93
5.10 PORTER’S FIVE FORCES ANALYSIS 94
5.11 PATENT ANALYSIS 97
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 99
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
5.12.2 BUYING CRITERIA 100
5.13 END-USER ANALYSIS 101
5.13.1 UNMET NEEDS 101
5.13.2 END-USER EXPECTATIONS 102
5.14 KEY CONFERENCES AND EVENTS, 2024–2025 103
5.15 CASE STUDY ANALYSIS 104
5.16 BUSINESS MODEL ANALYSIS 107
5.17 INVESTMENT AND FUNDING SCENARIO 108
5.18 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET 109
5.18.1 KEY USE CASES 110
5.18.2 CASE STUDY ON AI/GEN AI 110
5.18.3 ADJACENT MARKET ECOSYSTEM 111
5.18.3.1 Life science analytics market 111
5.18.3.2 Healthcare IT market 112
5.18.3.3 Healthcare fraud analytics market 112
5.18.4 USER READINESS AND IMPACT ASSESSMENT 112
5.18.4.1 User readiness 112
5.18.4.1.1 Payers 112
5.18.4.1.2 Providers 112
5.18.4.2 Impact assessment 113
5.18.4.2.1 User A: Payers 113
5.18.4.2.1.1 Implementation 113
5.18.4.2.1.2 Impact 113
 
5.18.4.2.2 User B: Providers 113
5.18.4.2.2.1 Implementation 113
5.18.4.2.2.2 Impact 114
6 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 115
6.1 INTRODUCTION 116
6.2 SERVICES 116
6.2.1 MANAGED SERVICES 118
6.2.1.1 Analytical services 120
6.2.1.1.1 Increasing volume of healthcare data to facilitate growth 120
6.2.1.2 Consulting services 121
6.2.1.2.1 Need to improve clinical outcomes and patient satisfaction to support growth 121
6.2.2 PROFESSIONAL SERVICES 122
6.2.2.1 Training & implementation services 124
6.2.2.1.1 Growing emphasis on value-based care and specialized training services to drive market 124
6.2.2.2 Maintenance & support services 125
6.2.2.2.1 Expanding research needs to propel demand for maintenance & support services 125
6.3 SOFTWARE 126
6.3.1 ON-PREMISE SOFTWARE 128
6.3.1.1 Provision of multi-vendor architecture and security benefits to drive market 128
6.3.2 CLOUD-BASED SOFTWARE 130
6.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption 130
7 HEALTHCARE ANALYTICS MARKET, BY TYPE 132
7.1 INTRODUCTION 133
7.2 DESCRIPTIVE ANALYTICS 133
7.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET 133
7.3 PREDICTIVE ANALYTICS 135
7.3.1 ABILITY OF PREDICTIVE ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS AVOID PREVENTABLE EVENTS TO SUPPORT GROWTH 135
7.4 PRESCRIPTIVE ANALYTICS 137
7.4.1 NEED FOR BETTER TREATMENT METHODS AND BUSINESS PRACTICES TO ENCOURAGE GROWTH 137
7.5 DIAGNOSTIC ANALYTICS 139
7.5.1 RISE IN LAUNCHES OF AI-DRIVEN ANALYTICS PRODUCTS AND SERVICES TO EXPEDITE GROWTH 139
 
8 HEALTHCARE ANALYTICS MARKET, BY APPLICATION 141
8.1 INTRODUCTION 142
8.2 FINANCIAL ANALYTICS 142
8.2.1 CLAIMS PROCESSING 144
8.2.1.1 Increasing shift from paper-based claims processing to electronic mode to augment growth 144
8.2.2 REVENUE CYCLE MANAGEMENT 146
8.2.2.1 Growing focus on financial forecasting and budgeting process to boost market 146
8.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE 147
8.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to drive market 147
8.2.4 RISK ADJUSTMENT & ASSESSMENT 149
8.2.4.1 Rise in special enrollment periods and new subsidies to accelerate growth 149
8.3 CLINICAL ANALYTICS 151
8.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING 153
8.3.1.1 Growing adoption of benchmarking to identify negative issues impacting healthcare systems to drive market 153
8.3.2 CLINICAL DECISION SUPPORT 154
8.3.2.1 Need to reduce medical errors and expedite diagnosis to boost market 154
8.3.3 REPORTING & COMPLIANCE 156
8.3.3.1 Ability to track regulatory changes, assess non-compliance, and perform internal audits to sustain growth 156
8.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS 157
8.3.4.1 Growing adoption of electronic health records to fuel market 157
8.3.5 PRECISION HEALTH/REAL-WORLD EVIDENCE 158
8.3.5.1 Strong government support for personalized medicine to sustain growth 158
8.3.6 MEDICAL IMAGING ANALYTICS 160
8.3.6.1 Ability to provide real-time insights and diagnosis of genetic disorders to aid growth 160
8.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS 161
8.4.1 SUPPLY CHAIN ANALYTICS 163
8.4.1.1 Growing need to reduce healthcare costs and implement better inventory management practices to fuel market 163
8.4.2 WORKFORCE ANALYTICS 165
8.4.2.1 Need for effective recruitment to favor growth 165
8.4.3 STRATEGIC ANALYTICS 166
8.4.3.1 Growing use of advanced analytics tools for geographic expansion and service line expansion to drive market 166
8.5 POPULATION HEALTH ANALYTICS 167
8.5.1 RISING USE IN CLINICAL OUTCOME ENGAGEMENT AND POPULATION RISK MANAGEMENT TO SPUR GROWTH 167
9 HEALTHCARE ANALYTICS MARKET, BY END USER 169
9.1 INTRODUCTION 170
9.2 PAYERS 170
9.2.1 PRIVATE INSURANCE COMPANIES 172
9.2.1.1 Increasing reliance on analytics for fraud prevention and claims processing to contribute to growth 172
9.2.2 GOVERNMENT AGENCIES 173
9.2.2.1 Rising use of analytics solutions to maximize payment accuracy and set reimbursement rates to boost market 173
9.3 PROVIDERS 174
9.3.1 HOSPITALS & CLINICS 176
9.3.1.1 Growing adoption of healthcare analytics solutions by large hospitals, medical groups, and physician practices to boost market 176
9.3.2 POST-ACUTE CARE ORGANIZATIONS 177
9.3.2.1 Increasing use of analytics solutions to review and study patient data to drive market 177
9.3.3 AMBULATORY SURGERY CENTERS 178
9.3.3.1 Need to control healthcare costs to support market 178
9.3.4 OTHER PROVIDERS 180
9.4 PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN 182
9.4.1 MANUFACTURERS 183
9.4.1.1 Growing adoption of digital technologies to drive market 183
9.4.2 DISTRIBUTORS & WHOLESALERS 185
9.4.2.1 Need for improved supply chain operations, inventory management, and service delivery to boost market 185
9.4.3 RETAILERS 186
9.4.3.1 Rising integration of healthcare analytics into retail operations to stimulate growth 186
10 HEALTHCARE ANALYTICS MARKET, BY REGION 187
10.1 INTRODUCTION 188
10.2 NORTH AMERICA 189
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 189
10.2.2 US 196
10.2.2.1 High adoption of electronic health records to drive market 196
10.2.3 CANADA 202
10.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market 202
10.3 EUROPE 208
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 208
10.3.2 GERMANY 214
10.3.2.1 Government initiatives to increase use of analytics in healthcare 214
10.3.3 UK 220
10.3.3.1 Availability of venture capital investments to drive market 220
10.3.4 FRANCE 225
10.3.4.1 Strong financial support for digital health to augment market 225
10.3.5 ITALY 231
10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions 231
10.3.6 SPAIN 236
10.3.6.1 Growing adoption of personalized medicine to drive market 236
10.3.7 REST OF EUROPE 241
10.4 ASIA PACIFIC 246
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 247
10.4.2 JAPAN 254
10.4.2.1 Rising geriatric population to drive demand for effective patient management solutions 254
10.4.3 CHINA 259
10.4.3.1 Favorable reforms and growing number of electronic health records to aid growth 259
10.4.4 INDIA 264
10.4.4.1 Favorable government initiatives to fuel market 264
10.4.5 REST OF ASIA PACIFIC 270
10.5 LATIN AMERICA 275
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 276
10.5.2 BRAZIL 282
10.5.2.1 Growing adoption of digital solutions in healthcare to boost market 282
10.5.3 MEXICO 288
10.5.3.1 Growing prominence of startups and rising R&D activity to propel market 288
10.5.4 REST OF LATIN AMERICA 293
10.6 MIDDLE EAST & AFRICA 298
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 299
10.6.2 GCC COUNTRIES 305
10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market 305
10.6.3 REST OF MIDDLE EAST & AFRICA 311
11 COMPETITIVE LANDSCAPE 317
11.1 INTRODUCTION 317
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2024 317
11.3 REVENUE ANALYSIS, 2019–2023 319
11.4 MARKET SHARE ANALYSIS, 2023 320
11.5 COMPANY EVALUATION AND FINANCIAL METRICS 322
11.6 BRAND/SOFTWARE COMPARISON 323
 
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 324
11.7.1 STARS 324
11.7.2 EMERGING LEADERS 324
11.7.3 PERVASIVE PLAYERS 324
11.7.4 PARTICIPANTS 324
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 326
11.7.5.1 Company footprint 326
11.7.5.2 Region footprint 327
11.7.5.3 Component footprint 328
11.7.5.4 Application footprint 329
11.7.5.5 End-user footprint 330
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 331
11.8.1 PROGRESSIVE COMPANIES 331
11.8.2 RESPONSIVE COMPANIES 331
11.8.3 DYNAMIC COMPANIES 331
11.8.4 STARTING BLOCKS 331
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 333
11.8.5.1 Detailed list of key startups/SMEs 333
11.8.5.2 Competitive benchmarking of key startups/SMEs 334
11.9 COMPETITIVE SCENARIO 335
11.9.1 PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES 335
11.9.2 DEALS 336
11.9.3 EXPANSIONS 337
12 COMPANY PROFILES 338
12.1 KEY PLAYERS 338
12.1.1 MERATIVE 338
12.1.1.1 Business overview 338
12.1.1.2 Products/Solutions/Services offered 339
12.1.1.3 Recent developments 339
12.1.1.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 339
12.1.1.3.2 Deals 340
12.1.1.4 MnM view 340
12.1.1.4.1 Key strengths 340
12.1.1.4.2 Strategic choices 340
12.1.1.4.3 Weaknesses and competitive threats 340
 
12.1.2 SAS INSTITUTE INC. 341
12.1.2.1 Business overview 341
12.1.2.2 Products/Solutions/Services offered 341
12.1.2.3 Recent developments 342
12.1.2.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 342
12.1.2.4 MnM view 343
12.1.2.4.1 Key strengths 343
12.1.2.4.2 Strategic choices 343
12.1.2.4.3 Weaknesses and competitive threats 343
12.1.3 OPTUM, INC. 344
12.1.3.1 Business overview 344
12.1.3.2 Products/Solutions/Services offered 345
12.1.3.3 Recent developments 346
12.1.3.3.1 Deals 346
12.1.3.4 MnM view 347
12.1.3.4.1 Key strengths 347
12.1.3.4.2 Strategic choices 347
12.1.3.4.3 Weaknesses and competitive threats 347
12.1.4 ORACLE 348
12.1.4.1 Business overview 348
12.1.4.2 Products/Solutions/Services offered 349
12.1.4.3 Recent developments 350
12.1.4.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 350
12.1.4.3.2 Deals 351
12.1.4.3.3 Expansions 352
12.1.4.4 MnM view 352
12.1.4.4.1 Key strengths 352
12.1.4.4.2 Strategic choices 352
12.1.4.4.3 Weaknesses and competitive threats 352
12.1.5 VERADIGM LLC 353
12.1.5.1 Business overview 353
12.1.5.2 Products/Solutions/Services offered 354
12.1.5.3 Recent developments 355
12.1.5.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 355
12.1.5.3.2 Deals 355
12.1.5.3.3 Expansions 357
12.1.5.3.4 Other developments 357
 
12.1.5.4 MnM view 357
12.1.5.4.1 Key strengths 357
12.1.5.4.2 Strategic choices 357
12.1.5.4.3 Weaknesses and competitive threats 358
12.1.6 EXLSERVICE HOLDINGS, INC. 359
12.1.6.1 Business overview 359
12.1.6.2 Products/Solutions/Services offered 360
12.1.6.3 Recent developments 361
12.1.6.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 361
12.1.6.3.2 Deals 361
12.1.6.3.3 Other developments 362
12.1.7 CITIUSTECH INC. 363
12.1.7.1 Business overview 363
12.1.7.2 Products/Solutions/Services offered 363
12.1.7.3 Recent developments 364
12.1.7.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 364
12.1.7.3.2 Deals 365
12.1.7.3.3 Expansions 365
12.1.7.3.4 Other developments 365
12.1.8 HEALTH CATALYST 366
12.1.8.1 Business overview 366
12.1.8.2 Products/Solutions/Services offered 367
12.1.8.3 Recent developments 368
12.1.8.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 368
12.1.8.3.2 Deals 368
12.1.9 CVS HEALTH 370
12.1.9.1 Business overview 370
12.1.9.2 Products/Solutions/Services offered 371
12.1.9.3 Recent developments 372
12.1.9.3.1 Deals 372
12.1.10 INOVALON 373
12.1.10.1 Business overview 373
12.1.10.2 Products/Solutions/Services offered 373
12.1.10.3 Recent developments 374
12.1.10.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 374
12.1.10.3.2 Deals 375
12.1.10.3.3 Expansions 375
12.1.10.3.4 Other developments 375
 
12.1.11 MCKESSON CORPORATION 376
12.1.11.1 Business overview 376
12.1.11.2 Products/Solutions/Services offered 377
12.1.11.3 Recent developments 378
12.1.11.3.1 Deals 378
12.1.12 MEDEANALYTICS, INC. 379
12.1.12.1 Business overview 379
12.1.12.2 Products/Solutions/Services offered 379
12.1.12.3 Recent developments 380
12.1.12.3.1 Deals 380
12.1.12.3.2 Other developments 380
12.1.13 COTIVITI, INC. 381
12.1.13.1 Business overview 381
12.1.13.2 Products/Solutions/Services offered 381
12.1.13.3 Recent developments 382
12.1.13.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 382
12.1.13.3.2 Other developments 382
12.1.14 APIXIO, INC. 383
12.1.14.1 Business overview 383
12.1.14.2 Products/Solutions/Services offered 383
12.1.14.3 Recent developments 384
12.1.14.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 384
12.1.14.3.2 Deals 385
12.1.15 ENLITIC 386
12.1.15.1 Business overview 386
12.1.15.2 Products/Solutions/Services offered 386
12.1.15.3 Recent developments 387
12.1.15.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 387
12.1.15.3.2 Deals 388
12.1.16 KOMODO HEALTH, INC. 389
12.1.16.1 Business overview 389
12.1.16.2 Products/Solutions/Services offered 389
12.1.16.3 Recent developments 390
12.1.16.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades 390
12.1.16.3.2 Deals 390
 
12.1.17 HEALTHEC, LLC 392
12.1.17.1 Business overview 392
12.1.17.2 Products/Solutions/Services offered 392
12.1.17.3 Recent developments 392
12.1.17.3.1 Deals 392
12.1.18 IQVIA 393
12.1.18.1 Business overview 393
12.1.18.2 Products/Solutions/Services offered 394
12.1.18.3 Recent developments 395
12.1.18.3.1 Deals 395
12.1.19 WIPRO 396
12.1.19.1 Business overview 396
12.1.19.2 Products/Solutions/Services offered 398
12.2 OTHER PLAYERS 399
12.2.1 ARCADIA SOLUTIONS, LLC. 399
12.2.2 EVIDATION HEALTH, INC. 399
12.2.3 HEALTHCORUM 400
12.2.4 AETION, INC. 400
12.2.5 TREDENCE.INC. 401
12.2.6 SISENSE LTD. 401
13 APPENDIX 402
13.1 DISCUSSION GUIDE 402
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 407
13.3 CUSTOMIZATION OPTIONS 409
13.4 RELATED REPORTS 409
13.5 AUTHOR DETAILS 410